Endometrial Cancer Trial, Recruiting NCT05909111 Sponsor: Recherche clinique Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT05909111
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have been diagnosed with cervical cancer confirmed by a tissue sample (specifically squamous cell carcinoma, adenocarcinoma, or a mixed type)
  • People whose treatment plan involves a combination of radiation therapy and chemotherapy with the goal of curing the cancer
  • People whose cancer is at a specific stage (FIGO/TNM Stage IB2, IIA, IIB, IIIA, or IIIB), with or without spread to nearby lymph nodes
  • People whose general health and ability to carry out daily activities meets a certain level (WHO performance score below 2)
  • People who are not pregnant
  • People who are covered by a social security or health insurance scheme
  • People who have given their free, informed, and written agreement to take part, signed before any trial-related procedures begin

Who may not be able to join:

  • People whose cancer has spread to distant parts of the body (metastatic disease)
  • People who are unable to have an MRI scan — for example, due to claustrophobia or having certain metal implants or devices in their body
  • People who have signs of an active infection or other serious health problems
  • People who have previously received radiation therapy to the abdomen or pelvis
  • People who have previously had surgery to remove part or all of the uterus (partial or total hysterectomy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0490276543

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Recherche clinique
Registry
ClinicalTrials.gov
Start date
1 December 2022
Est. completion
1 February 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Tumor regression assessment CBCT; Tumor regression assessment MRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov